Article

Transcription factor 19 is an androgen responsive gene that modulates vessel homeostasis and sustains metastatic prostate cancer

2025-02-08

Abstract excerpt

Prostate cancer is a prevalent tumor type that, despite being highly curable, progresses to metastatic disease in a fraction of patients, thus accounting for more than 350.000 annual deaths worldwide. In turn, uncovering the molecular insights of metastatic disease is instrumental to improve the survival rate of prostate cancer patients. By means of gene expression metanalysis in multiple prostate cancer patient c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d0c4b801-6f38-5b57-94fe-89a6439f854a
DOI: 10.1101/2025.02.04.636232

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Transcription factor 19 is an androgen responsive gene that modulates vessel homeostasis and sustains metastatic prostate cancerDOI 10.1101/2025.02.04.636232Read

The transcriptional landscape of metastatic hormone-naïve prostate cancerSemantic proximity Read

Super-Enhancer Network in Metastatic Prostate Cancer: A Bioinformatics and Experimental ApproachSemantic proximity Read

Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancerSemantic proximity Read

Independence of HIF1a and androgen signaling pathways in prostate cancerSemantic proximity Read

Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate CancerSemantic proximity Read

CDK19 and CDK8 Mediator kinases drive androgen-independent <i>in vivo</i> growth of castration-resistant prostate cancerSemantic proximity Read

Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer ProgressionSemantic proximity Read

The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancerSemantic proximity Read

Immunotherapeutic Value of Transcription Factor 19 (TCF19) Associated with Renal Clear Cell Carcinoma: A Comprehensive Analysis of 33 Human Cancer CasesSemantic proximity Read

CRISPR screening reveals gleason score and castration resistance related oncodriver ring finger protein 19 A (RNF19A) in prostate cancerSemantic proximity Read

Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markersSemantic proximity Read

Androgen-targeted hsa_circ_0085121 encodes a novel protein and improves the development of prostate cancer through facilitating the activity of PI3K/Akt/mTOR pathway and enhancing AR-V7 alternative splicingSemantic proximity Read